Intravitreal injections with aflibercept (Eylea) don’t improve the visible acuity of of us with nonproliferative diabetic retinopathy (NPDR), researchers exclaim. The therapies originate sever the…
Intravitreal injections with aflibercept (Eylea) don’t improve the visible acuity of of us with nonproliferative diabetic retinopathy (NPDR), researchers exclaim. The therapies originate sever the…